Clarus Lifesciences III L.P. 13D and 13G filings for Entasis Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-09 4:48 pm Sale |
2020-07-02 | 13D | Entasis Therapeutics Holdings Inc. ETTX |
Clarus Lifesciences III L.P. | 1,339,836 4.900% |
-283,569 (-17.47%) |
Filing |
| 2020-05-01 5:01 pm Unchanged |
2019-04-22 | 13D | Entasis Therapeutics Holdings Inc. ETTX |
Clarus Lifesciences III L.P. | 1,623,405 11.100% |
0 (Unchanged) |
Filing |